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1. Introduction
  Malaria is one of the most prevalent parasitic infections 
in the world[1], with 225 million cases and 0.78 million 
deaths in 2009, mainly in Africa, Asia and South 
America. Four species of Plasmodium affect humans, but 
more recently Plasmodium knowlesi was described in 
Southeast Asia as a fifth species in primates that rarely 
affects men[2]. However, the most important species 
that contribute to increased morbidity and mortality in 
humans are Plasmodium falciparum (P. falciparum) and 
Plasmodium vivax (P. vivax)[1].
  After P. falciparum, infection with P. vivax is the second 
most common cause of malaria in the world. It is difficult 
to treat P. vivax because of the hypnozoites and frequent 
relapses after initial management[1,3]. The previous old 
paradigm of P. vivax as “benign tertian malaria” has 
been challenged recently by reports of severe disease 
with complications such as acute respiratory distress 
syndrome, acute renal failure, severe thrombocytopenia, 
retinal hemorrhage, toxic shock, and cerebral malaria[4-10]. 
The purpose of this report is to describe a case of cerebral 
malaria as a complication of P. vivax infection.
2. Case report
  A 22 year old male professional soldier was referred from 
the South Pacific coast of Colombia to Hospital San Vicente 
de Paúl (Medellín, Colombia), a high complexity referral 
hospital, with 1 week of subjective fever, malaise and 
headache. At admission to the emergency room, he was 
stuporous and febrile without neck stiffness or focal motor 
signs. Later, he presented two generalized tonic-clonic 
seizures. With Glasgow Coma Scale of 7/15 in the postictal 
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state, he required mechanical ventilation support and was 
transferred to the intensive care unit. 
  Initial laboratories showed 55.300 platelets/mm3, 
creatinine 1.34 mg/dL, serum glucose 142 mg/dL, lactate 
2.7 mmol/L, aspartate aminotranferase 98 U/L, alanine 
aminotranferase 81.9 U/L, total bilirubin 1.6 mg/dL, indirect 
bilirubin 1.2 mg/dL, activated partial-thromboplastin 
time 35.1 s (control of 26 s), and hemoparasite test reported 
3.280 parasites/毺L of P. vivax. Treatment was started with 
intravenous quinine plus clindamycin under suspicion of 
mixed infection with P. falciparum. The different tests ruled 
out metabolic disorders as a cause of seizures and blood 
cultures for bacteria were negative. No additional study was 
performed to rule out coagulopathy.
  Cerebrospinal fluid analysis was normal. Brain computed 
tomography was normal but magnetic resonance imaging 
with gadolinium showed suggestive images of incipient 
meningeal inflammatory process and partial thrombosis in 
superior sagittal sinus (Figure 1). Seriated hemoparasite tests 
were performed and we only found P. vivax gametocytes. 
The polymerase chain reaction (PCR) for malaria ruled out 
mixed infection. The patient completely recovered and had 
negative thick for hemoparasites after treatment.  
 
Figure 1. Saggital T1 slice.
Signal hyperintensity in superior sagittal sinus suggestive of venous 
sinus thrombosis (arrow). Evidence with the contrast of filling defect in 
the posterior portion of the sagittal sinus.
 
3. Discussion
  Severe malaria is associated to P. falciparum and accounts 
for increased mortality worldwide[1]. P. vivax has been 
neglected in clinical studies of severe malaria and the 
incidence and cause of complications are unknown[11]. 
Previous studies believed that P. vivax was unable to 
produce cytoadherence with microvascular sequestration, 
therefore, it was considered impossible to cause organ 
dysfunction like in P. falciparum malaria. Recently, 
sequestration of P. vivax in the pulmonary vasculature has 
been noted and it is believed that organic dysfunction can 
be generated by an inflammatory response amplified by the 
release of cytokines[12,13]. 
  However, there is little known about this presentation with 
P. vivax and its relation with individual immune status. 
Cerebral complications have been described in 45 patients, 
the majority in children from India and Pakistan. In 1921, 
Rossle described a lethal hemorrhage in the cerebellum of 
a 21 year old patient during a course of tertian malaria[14]. 
In 1932, Bruetsch reported a 61 year old woman with fatal 
tertian malaria induced as treatment for syphilitic psychosis; 
at autopsy “numerous parasitized red blood cells and 
young plasmodia” were observed in brain tissue[15]. Other 
complications mentioned are mainly seizures, altered 
consciousness reaching even coma, acute inflammatory 
demyelinating polyneuropathy and facial paralysis. Only four 
of these cases were single infections of P. vivax documented 
by PCR[16,17].
  Cerebral malaria manifested by isolated bilateral sixth 
cranial nerve palsy is rare in adults but more commonly 
described in children[18-23]. Vinod and Talari recently 
reported a 13 year old girl with intermittent fever for 
20 d, repeated generalized tonic clonic seizures and 
unconsciousness for 1 d; her brain enhanced CT showed 
diffuse cerebral oedema; peripheral blood film did not show 
parasites, but quantitative buffy coat technique revealed P. 
vivax; and Plasmodium LDH immunochromatographic test 
was also positive for P. vivax[24,25]. Krishnan et al. described 
three adults with P. falciparum malaria with fever, altered 
consciousness and focal neurological deficits (one of whom 
also had seizures); brain CT scan showed haemorrhagic 
infarction of the cerebral cortex and subcortical white matter 
with surrounding oedema suggestive of venous infarction in 
all of them; the diagnosis of cerebral venous thrombosis was 
missed in the first case and was detected only at autopsy; 
in the other two patients, superior sagittal sinus thrombosis 
was confirmed angiographically, one patient survived and 
the other died due to increased intracranial pressure, two 
of them had P. vivax co-infection[26,27]. Another report by 
Sarkar and Bhattacharya shows three adult patients with 
P. vivax malaria complicated by seizures and symptoms of 
diffuse meningoencephalitis[10]. More recently, the same 
author presented the first case of P. vivax malaria with left 
thalamus haemorrhage which is an unusual site of bleeding 
even more in the absence of severe thrombocytopenia or 
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disseminated intravascular coagulation[28].
  This clinical scenarios show how P. vivax infection could 
lead to involvements other than the commonly described 
ones with different outcomes and should call our attention 
in order to rule out this co-infection when severe malaria 
appeared even if routine test shows P. falciparum; besides, 
we must watch closely patients with neurological findings 
because they could have sinus thrombosis, like our case 
who is the first confirmed by PCR in Latin America. 
Although we do not clarify the cause of the superior 
sagittal sinus thrombosis in this patient and there were 
no clear consequences of this event, we believe that this 
information can be added to future studies to enable a better 
understanding of the disease.
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